Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Bruker Corporation (BRKR) shares
Learn how to easily invest in Bruker Corporation shares.
Bruker Corporation is a medical devices business based in the US. Bruker Corporation stocks (BRKR.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $79.04 – a decrease of 6.01% over the previous week. Bruker Corporation employs 7,400 staff and has a trailing 12-month revenue of around $2.4 billion.
How to buy shares in Bruker Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BRKR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Bruker Corporation?
- Has coronavirus impacted Bruker Corporation shares?
- Bruker Corporation shares summary
- Compare share dealing platforms
- Is Bruker Corporation stock a buy or sell?
- Bruker Corporation performance over time
- Are Bruker Corporation shares over-valued?
- Bruker Corporation's financials
- How volatile are Bruker Corporation shares?
- Does Bruker Corporation pay a dividend?
- Other common questions
Bruker Corporation stock price (NASDAQ:BRKR)Use our graph to track the performance of BRKR stocks over time.
Bruker Corporation shares at a glance
|Latest market close||$66.47|
|52-week range||$54.34 - $92.31|
|50-day moving average||$80.08|
|200-day moving average||$77.66|
|Wall St. target price||$86.82|
|Dividend yield||$0.16 (0.28%)|
|Earnings per share (TTM)||$1.77|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Bruker Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Bruker Corporation price performance over time
|1 week (2022-01-13)||-6.08%|
|1 month (2021-12-18)||N/A|
|3 months (2021-10-21)||-15.09%|
|6 months (2021-07-22)||-18.44%|
|1 year (2021-01-22)||9.25%|
|2 years (2020-01-22)||24.97%|
|3 years (2019-01-22)||93.96%|
|5 years (2017-01-20)||197.94%|
Is Bruker Corporation under- or over-valued?
Valuing Bruker Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bruker Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bruker Corporation's P/E ratio
Bruker Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, Bruker Corporation shares trade at around 40x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Bruker Corporation's PEG ratio
Bruker Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.64. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bruker Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Bruker Corporation's EBITDA
Bruker Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $507.6 million.
The EBITDA is a measure of a Bruker Corporation's overall financial performance and is widely used to measure a its profitability.
Bruker Corporation financials
|Revenue TTM||$2.4 billion|
|Operating margin TTM||17.77%|
|Gross profit TTM||$944.4 million|
|Return on assets TTM||8.73%|
|Return on equity TTM||26.88%|
|Market capitalisation||$10.7 billion|
TTM: trailing 12 months
Bruker Corporation share dividends
Dividend payout ratio: 9.04% of net profits
Recently Bruker Corporation has paid out, on average, around 9.04% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.28% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Bruker Corporation shareholders could enjoy a 0.28% return on their shares, in the form of dividend payments. In Bruker Corporation's case, that would currently equate to about $0.16 per share.
While Bruker Corporation's payout ratio might seem low, this can signify that Bruker Corporation is investing more in its future growth.
Bruker Corporation's most recent dividend payout was on 16 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 November 2021 (the "ex-dividend date").
Bruker Corporation share price volatility
Over the last 12 months, Bruker Corporation's shares have ranged in value from as little as $54.3429 up to $92.306. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bruker Corporation's is 1.2311. This would suggest that Bruker Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Bruker Corporation overview
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Bruker Corporation in the news
Bruker : MetaboParis-Santé platform first in France to Install Bruker In Vitro Diagnostic Research by NMR* System at Université de Paris
Retirement Systems of Alabama Buys Applied Materials Inc, Broadcom Inc, Johnson & Johnson, ...
New Mexico Educational Retirement Board Buys Alcoa Corp, EPAM Systems Inc, Bruker Corp, Sells ...
Frequently asked questions
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.